FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
7237811000172118 referentieset voor associaties betreffende vervangende concepten nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)


15419 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Chlorpromazine hydrochloride 30mg m/r capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 30mg prolonged-release oral capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 50mg/5mL syrup Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)
Chlorpromazine hydrochloride 75mg m/r capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 75mg prolonged-release oral capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorprothixene overdose Chlorprothixene overdose (disorder)
Chlortetracycline hydrochloride 3% ointment Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug)
Cholesterol analyte Cholesterol
Cholesterol reduction program - declined Cholesterol reduction programme declined
Cholestyramine + sucrose Product containing colestyramine (medicinal product)
Cholestyramine 4g powder Colestyramine 4 g powder for oral suspension sachet
Cholestyramine 4g suspension Colestyramine 4 g powder for oral suspension sachet
Cholestyramine 4g/unit powder Colestyramine 4 g powder for oral suspension sachet
Cholestyramine 4g/unt powder Colestyramine 4 g powder for oral suspension sachet
Cholestyramine+aspartame Product containing colestyramine (medicinal product)
Cholestyramine+aspartame 4g/sachet powder Colestyramine 4 g powder for oral suspension sachet
Choline salicylate 870mg/5ml liquid Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug)
Choline salicylate+glycerol 20%/12.6% ear drops Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug)
allergie au théophyllinate de choline Allergy to theophylline (finding)
Chondrocalcinosis due to dicalcium phosphate crystals, NOS Chondrocalcinosis due to dicalcium phosphate crystals
Chondrocalcinosis due to dicalcium phosphate crystals, of other specified site Chondrocalcinosis due to dicalcium phosphate crystals
Chondrocalcinosis due to dicalcium phosphate crystals, of unspecified site Chondrocalcinosis due to dicalcium phosphate crystals
Chondrocyte cell Chondrocyte (substance)
Chondrosarcoma - category Chondrosarcoma
Chondrosarcoma, no International Classification of Diseases for Oncology subtype Chondrosarcoma
Choriocarcinoma, no International Classification of Diseases for Oncology subtype Choriocarcinoma (morphologic abnormality)
Choriogonadotropin alfa 10,000iu powder and solvent for injection solution ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 10,000iu powder for conventional release solution for injection ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 1500iu powder and solvent for injection solution ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 1500iu powder for conventional release solution for injection ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 2000iu powder and solvent for injection solution ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 5000iu powder and solvent for injection solution ampule Product containing only choriogonadotropin (medicinal product)
Choriogonadotropin alfa 5000iu powder for conventional release solution for injection ampule Product containing only choriogonadotropin (medicinal product)
Choroid meningioma Meningioma, chordoid (morphologic abnormality)
Choroid plexus papilloma, no International Classification of Diseases for Oncology subtype Benign choroid plexus papilloma (morphologic abnormality)
Choroideremia co-occurrent with hypopituitarism Choroideremia with deafness and obesity syndrome (disorder)
Chromic phosphate, p-32 15mCi injection suspension 10mL vial Chromic phosphate (32-P) only product in parenteral dose form
Chromic phosphate, p-32 7.0mil/mL injection Chromic phosphate (32-P) only product in parenteral dose form
Chromic phosphate[32P] 185MBq/mL injection Chromic phosphate (32-P) only product in parenteral dose form
Chromic phosphate[32P] 185MBq/mL powder for injection solution vial Chromic phosphate (32-P) only product in parenteral dose form
Chromobacterium fluviatile Iodobacter fluviatilis
Chromobacterium lividum Janthinobacterium lividum (organism)
Chromosome replaced with ring or dicentric Ring chromosome
Chronic active type A viral hepatitis Viral hepatitis, type A
Chronic aggressive type A viral hepatitis Viral hepatitis, type A
Chronic angle-closure glaucoma Chronic angle-closure glaucoma
Chronic antritis Chronic maxillary sinusitis
Chronic cyclitis Intermediate uveitis
Chronic erythremia Polycythemia vera
Chronic erythremia Polycythemia vera (clinical)
Chronic erythremia Polycythemia vera (clinical)
Chronic erythremia in remission Polycythemia vera (clinical)
Chronic female pelvic peritonitis Chronic inflammation of pelvic peritoneum (disorder)
Chronic infection Chronic infectious disease
iridocyclite chronique due à une autre affection Iridocyclitis
Chronic kidney disease clinical management plan Chronic kidney disease clinical management plan (record artifact)
Chronic leukemia - category Chronic leukemia (morphologic abnormality)
Chronic lymphoid leukemia - category B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma
Chronic lymphoproliferative disease Lymphoproliferation of uncertain behavior (morphologic abnormality)
Chronic monocytic leukemia Myeloid leukaemia
chronische monocytaire leukemie Chronic myelomonocytic leukaemia
Chronic monocytic leukemia in remission Myeloid leukemia in remission
ostéomyélite multifocale chronique Chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis
Chronic multifocal osteomyelitis Chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis
BCR/ABL-positieve chronische myeloïde leukemie Chronic myeloid leukemia (morphologic abnormality)
Chronic myelogenous leukemia, no International Classification of Diseases for Oncology subtype Chronic myeloid leukemia (morphologic abnormality)
Chronic myeloid leukemia - category Chronic myeloid leukemia (morphologic abnormality)
Chronic myelomonocytic leukemia Chronic myelomonocytic leukaemia
Chronic myeloproliferative disease, no International Classification of Diseases for Oncology subtype Malignant myeloproliferative neoplasm (morphologic abnormality)
Chronic myeloproliferative disorder Malignant myeloproliferative neoplasm (morphologic abnormality)
Chronic necrotizing pulmonary aspergillosis Subacute invasive pulmonary aspergillosis (disorder)
Chronic neurogenic ulcer of skin Neurogenic ulcer
Chronic non-A non-B hepatitis Chronic viral hepatitis
maladie pulmonaire chronique non spécifique Chronic lung disease (disorder)
Chronic obstructive airway disease with asthma Asthma-chronic obstructive pulmonary disease overlap syndrome
Chronic obstructive pulmonary disease clinical management plan Chronic obstructive pulmonary disease clinical management plan (record artifact)
Chronic osteomyelitis of other specific site, NEC Chronic osteomyelitis
Chronic persistent type A viral hepatitis Viral hepatitis, type A
Chronic polyarticular juvenile rheumatoid arthritis Polyarticular juvenile idiopathic arthritis
Chronic postrheumatic arthropathy Jaccoud's syndrome
Chronic pyelonephritis Chronic pyelonephritis
maladie respiratoire chronique en période périnatale Chronic respiratory disease originating in perinatal period (disorder)
Chronic secretory otitis media Chronic mucoid otitis media
Chronic trophic ulcer of other specified site Chronic trophic ulcer of skin
Chronic type A viral hepatitis Viral hepatitis, type A
Chronic ulcer of other specified site Chronic ulcer of skin (disorder)
Chronic uremia Chronic renal failure
Chronic yellow atrophy of liver Chronic necrosis of liver
Chronobiologic disorder Abnormal chronobiologic state (finding)
Chryseobacterium meningosepticum Elizabethkingia meningoseptica (organism)
Chryseobacterium miricola Elizabethkingia miricola (organism)
Chryseobacterium scopthalmum Chryseobacterium scophthalmum (organism)
Chryseomonas species Pseudomonas
Chudley Lowry Hoar syndrome Alpha thalassemia X-linked intellectual disability syndrome (disorder)
Chymopapain extract Product containing chymopapain (medicinal product)
Ciclesonide 160micrograms inhaler Product containing only ciclesonide in pulmonary dose form (medicinal product form)
Ciclesonide 80micrograms inhaler Product containing only ciclesonide in pulmonary dose form (medicinal product form)
Ciclopirox 0.77% topical suspension Product containing precisely ciclopirox (as ciclopirox olamine) 7.7 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)
Ciclopirox olamine 8% solution Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
Cidofovir 75mg/mL infusion concentrate 5mL vial Cidofovir 75 mg/mL solution for injection

Start Previous Page 23 of 155 Next End


Reference Sets

Reference set descriptor

Back to Start